<?xml version="1.0" encoding="UTF-8"?>
<p id="par0110">Baricitinib is a selective Janus kinase 1 and Janus kinase 2 (JAK1 and JAK2) inhibitor. The mechanism of action is considered to be by modulation of viral endocytosis. But there are huge concerns that this blockage may potentiate SARS-Cov2 infection, and there are other safety issues related to this productâ€™s administration [
 <xref rid="bib0200" ref-type="bibr">40</xref>].
</p>
